95 related articles for article (PubMed ID: 21115910)
1. Stilbenes as multidrug resistance modulators and apoptosis inducers in human adenocarcinoma cells.
Wesolowska O; Wisniewski J; Bielawska-Pohl A; Paprocka M; Duarte N; Ferreira MJ; Dus D; Michalak K
Anticancer Res; 2010 Nov; 30(11):4587-93. PubMed ID: 21115910
[TBL] [Abstract][Full Text] [Related]
2. Modulation of multidrug resistance by andrographolid in a HCT-8/5-FU multidrug-resistant colorectal cancer cell line.
Han Y; Bu LM; Ji X; Liu CY; Wang ZH
Chin J Dig Dis; 2005; 6(2):82-6. PubMed ID: 15904426
[TBL] [Abstract][Full Text] [Related]
3. A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells.
Bartolini G; Orlandi M; Papi A; Ammar K; Guerra F; Ferreri AM; Rocchi P
In Vivo; 2006; 20(6A):729-33. PubMed ID: 17203756
[TBL] [Abstract][Full Text] [Related]
4. Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells.
Ravizza R; Gariboldi MB; Molteni R; Monti E
Oncol Rep; 2008 Sep; 20(3):625-30. PubMed ID: 18695915
[TBL] [Abstract][Full Text] [Related]
5. Effect of cycloartanes on reversal of multidrug resistance and apoptosis induction on mouse lymphoma cells.
Madureira AM; Spengler G; Molnár A; Varga A; Molnár J; Abreu PM; Ferreira MJ
Anticancer Res; 2004; 24(2B):859-64. PubMed ID: 15161038
[TBL] [Abstract][Full Text] [Related]
6. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Xu HB; Li L; Liu GQ
Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169
[TBL] [Abstract][Full Text] [Related]
7. Reversal of multidrug resistance by synthetic and natural compounds in drug-resistant MCF-7 cell lines.
Kars MD; Işeri OD; Gunduz U; Molnar J
Chemotherapy; 2008; 54(3):194-200. PubMed ID: 18560226
[TBL] [Abstract][Full Text] [Related]
8. Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells.
Ganta S; Amiji M
Mol Pharm; 2009; 6(3):928-39. PubMed ID: 19278222
[TBL] [Abstract][Full Text] [Related]
9. Inhibit multidrug resistance and induce apoptosis by using glycocholic acid and epirubicin.
Lo YL; Ho CT; Tsai FL
Eur J Pharm Sci; 2008 Sep; 35(1-2):52-67. PubMed ID: 18606222
[TBL] [Abstract][Full Text] [Related]
10. Overview how adenocarcinoma cancer cells avoid immune- and chemotherapy-induced apoptosis.
Pajak B; Orzechowski A
Adv Med Sci; 2006; 51():39-45. PubMed ID: 17357275
[TBL] [Abstract][Full Text] [Related]
11. Sanguinarine overcomes P-glycoprotein-mediated multidrug-resistance via induction of apoptosis and oncosis in CEM-VLB 1000 cells.
Weerasinghe P; Hallock S; Tang SC; Trump B; Liepins A
Exp Toxicol Pathol; 2006 Aug; 58(1):21-30. PubMed ID: 16735106
[TBL] [Abstract][Full Text] [Related]
12. Antimultidrug-resistant effect and mechanism of a novel CA-4 analogue MZ3 on leukemia cells.
Xu D; Fang L; Zhu Q; Hu Y; He Q; Yang B
Pharmazie; 2008 Jul; 63(7):528-33. PubMed ID: 18717489
[TBL] [Abstract][Full Text] [Related]
13. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
[TBL] [Abstract][Full Text] [Related]
14. A novel podophyllotoxin derivative (YB-1EPN) induces apoptosis and down-regulates express of P-glycoprotein in multidrug resistance cell line KBV200.
Chen H; Bi W; Cao B; Yang Z; Chen S; Shang H; Yu P; Yang J
Eur J Pharmacol; 2010 Feb; 627(1-3):69-74. PubMed ID: 19879873
[TBL] [Abstract][Full Text] [Related]
15. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance modulation and apoptosis induction of cancer cells by terpenic compounds isolated from Euphorbia species.
Duarte N; Ramalhete C; Varga A; Molnár J; Ferreira MJ
Anticancer Res; 2009 Nov; 29(11):4467-72. PubMed ID: 20032393
[TBL] [Abstract][Full Text] [Related]
17. New 1,3-dioxolane and 1,3-dioxane derivatives as effective modulators to overcome multidrug resistance.
Schmidt M; Ungvári J; Glöde J; Dobner B; Langner A
Bioorg Med Chem; 2007 Mar; 15(6):2283-97. PubMed ID: 17276076
[TBL] [Abstract][Full Text] [Related]
18. A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells.
Shuhendler AJ; Cheung RY; Manias J; Connor A; Rauth AM; Wu XY
Breast Cancer Res Treat; 2010 Jan; 119(2):255-69. PubMed ID: 19221875
[TBL] [Abstract][Full Text] [Related]
19. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis and necrosis by resistance modifiers benzazoles and benzoxazines on tumour cell line mouse lymphoma L5718 Mdr+cells.
Varga A; Aki-Sener E; Yalcin I; Temiz-Arpaci O; Tekiner-Gulbas B; Cherepnev G; Molnar J
In Vivo; 2005; 19(6):1087-91. PubMed ID: 16277027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
